Finland· FI-REL-REL64324
Aujemflu
A influenza, inaktiviert, spalt/split virus oder oberflächen-antigen product containing a/wisconsin/67/2022 (h1n1)pdm09-like strain (a/georgia/12/2022 cvr-167) + influenza a virus, subtype h3n2, strain a/district of columbia/27/2023-like virus a/victoria/800/2024 cvr-289, live + b/austria/1359417/2021-like strain (b/singapore/wuh4618/2021), registered in Finland by Seqirus Netherlands B.V.. The same ATC class is registered in 11 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Influenza, inaktiviert, spalt/split virus oder oberflächen-antigen is registered in 11 of 19 countries.
Countries holding a registration under ATC J07BB02 (influenza, inaktiviert, spalt/split virus oder oberflächen-antigen), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 7 of them publish a price we can compare per daily dose
Influenza, inaktiviert, spalt/split virus oder oberflächen-antigen · ATC J07BB02
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Fimea (Finland)- Active substance
- A/Wisconsin/67/2022 (H1N1)pdm09-like strain (A/Georgia/12/2022 CVR-167) + Influenza A virus, subtype H3N2, strain A/District of Columbia/27/2023-like virus A/Victoria/800/2024 CVR-289, Live + B/Austria/1359417/2021-like strain (B/Singapore/WUH4618/2021)
- Manufacturer
- Seqirus Netherlands B.V.
- Country
- Finland (FI)
- ATC code
- J07BB02
- ATC class
- Influenza, inaktiviert, Spalt/Split Virus oder Oberflächen-Antigen
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07BB02
Influenza, inaktiviert, spalt/split virus oder oberflächen-antigen, as other registers publish it.
- IcelandAdjupanrixGlaxoSmithKline Biologicals S.A.*
- PolandAdjupanrixGlaxoSmithKline Biologicals S.A.
- BelgiumAdjupanrixGlaxoSmithKline Biologicals
- DenmarkAdjupanrixGlaxoSmithKline Biologicals S.A.
- FinlandAdjupanrixGlaxoSmithKline Biologicals SA
- CzechiaADJUPANRIXGlaxoSmithKline Biologicals S.A., Rixensart
- IrelandAdjupanrix suspension and emulsion for emulsion for injection. Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted)GlaxoSmithKline Biologicals S.A.
- NetherlandsAdjupanrix, (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals, suspensie en emulsie voor emulsie voor injectieGlaxoSmithKline Biologicals S.A.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/be11c805-4a3a-48cf-9c5b-83eedcdc9693 GET /v1/drugs/be11c805-4a3a-48cf-9c5b-83eedcdc9693?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "injektioneste, suspensio, esitäytetty ruisku",
"route": "Lihakseen",
"ddd_unit": null,
"strength": null,
"atc_label": "influenssarokote, puhdistettu antigeeni",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/26/2050/001-004",
"fimea_rel_id": "REL64324",
"authorised_at": "2026-08-20"
}See everything about influenza, inaktiviert, spalt/split virus oder oberflächen-antigen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.